Elsevier

The Lancet

Volume 365, Issue 9474, 28 May–3 June 2005, Pages 1827-1829
The Lancet

Comment
Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors

https://doi.org/10.1016/S0140-6736(05)66588-9Get rights and content

First page preview

First page preview
Click to open first page preview

References (2)

  • C De Angelis et al.

    Clinical trial registration: a statement from the International Committee of Medical Journal Editors

    Lancet

    (2004)
  • Guidance for industry information program on clinical trials for serious or life-threatening diseases and conditions

Cited by (77)

  • Increasing value and reducing waste: Addressing inaccessible research

    2014, The Lancet
    Citation Excerpt :

    Prospective, public registration of all studies at their inception is the key mechanism by which existing studies can be tracked. Since 2005, the International Committee of Medical Journal Editors has asked that clinical trials be registered prospectively in an approved registry as a condition of publication.92 Subsequent legislation in several countries has extended the mandate for trials included in submissions to regulators,93 and several government funders have registration of trials as a condition of grant approval.94,95

  • Misleading abstract conclusions in randomized controlled trials in rheumatology: Comparison of the abstract conclusions and the results section

    2012, Joint Bone Spine
    Citation Excerpt :

    The existence of adverse effects can have a major impact on whether a particular intervention is deemed acceptable and useful, and readers need both efficacy and safety results to make rational and balanced decisions. It is now mandatory for a trial to be registered before publication [31], but only 40 articles (27.8%) in our sample did so. Of these, 16 (40.0%) declared the information in the text and 15 (37.5%) reported a PO different from the registered one, which agrees with other recent findings [32].

  • Outcomes in Clinical Trials Evaluating Interventions for the Prevention and Treatment of Hepatic Encephalopathy

    2019, Journal of Clinical and Experimental Hepatology
    Citation Excerpt :

    Clinical trials should, in line with the policy of the World Health Organisation (WHO) and the International Committee of Medical Journal Editors (ICMJE), be registered in a publicly owned, publicly accessible registry and should satisfy a minimum data set.70,71 This policy requires that any clinical trial initiated after July 1, 2005, irrespective of the assessed intervention, should be prospectively registered as a prerequisite for manuscript submission.70,71 Trial registration should take place before or at the time of enrolment of the first participant in the trial.

View all citing articles on Scopus
View full text